Abstract
The ability to continuously monitor fluctuating concentrations of specific molecules in the body can drastically improve precision medicine by allowing the real-time correlation of dynamic molecular processes with health and disease. While this ability has been pursued from multiple directions, electrochemical strategies have been successful and commercializable platforms. For example, continuous glucose monitors have dramatically improved the therapeutic management and quality of life for Type 1 diabetics. Unfortunately, the enzymatic sensing used in glucose monitors is not applicable to a large number of clinically relevant biomarkers. This limitation significantly reduces the scope of dynamic biochemical processes we can probe to study healthy human physiology and disease. In response, my laboratory is developing in vivo electrochemical aptamer-based sensors, a platform that is generalizable to the highly specific sensing of arbitrary molecular targets and supports continuous molecular monitoring in the body. In this presentation I will discuss the current state-of-the-art of these sensors, and the challenges we are addressing to enable preclinical and clinical applications. Figure 1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.